Phase IV Clinical Trial (STAR Study) Extension Study of Conbercept Ophthalmic Injection for Treatment of Polypoid Choroidal Vasculopathy
Clinical trial NCT03244657 · UNKNOWN
Trial details
- NCT number
- NCT03244657
- Sponsor
- Chengdu Kanghong Biotech Co., Ltd.
- Status
- UNKNOWN
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2017-04-25
- Primary completion
- 2019-10-31
- Enrollment
- 200
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.